13 Nov 2020 --- Clinical nutrition specialist Kate Farms has raised US$51 million in Series B funding to help meet the increasing demand for plant-based options across industries. The funding round for the manufacturer of organic, allergen-free and plant-based formulas to nourish those with chronic illnesses was led by Goldman Sachs, Kaiser Permanente and other existing individual investors.